Cambridge's Relay Therapeutics lands $400M round led by SoftBank

Relay uses computer models to study how proteins move and fold, which it hopes will provide insights into how a protein's structure influences its functions and enable the company to create more efficient cancer treatments.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.